Analyst Ratings January 26, 2026

KBW Lifts Webster Financial Price Target to $77 After Strong Q4; Maintains Outperform

Analyst firm cites stronger loan growth momentum, credit improvement and the bank's largest buyback quarter of 2025 as reasons for modest target increase

By Ajmal Hussain WBS
KBW Lifts Webster Financial Price Target to $77 After Strong Q4; Maintains Outperform
WBS

Keefe, Bruyette & Woods raised its price objective on Webster Financial (WBS) to $77 from $75 while holding its Outperform rating. KBW points to robust fourth-quarter results, accelerating loan growth trends, and improving credit quality through 2025, along with the company's strongest buyback quarter of 2025. Webster also reported an earnings and revenue beat for Q4 2025, though the stock saw a small pre-market decline and no analyst upgrades or downgrades followed the release.

Key Points

  • KBW raised its price target on Webster Financial to $77 from $75 and reiterated an Outperform rating.
  • KBW cited strong Q4 results, accelerating loan growth momentum, improving credit quality through 2025, and Webster's strongest buyback quarter of 2025 as reasons for the outlook.
  • Webster's Q4 2025 results beat expectations with EPS of $1.59 (vs. $1.53 forecast) and revenue of $746.2 million (vs. $731.51 million forecast) - however, the stock dipped slightly in pre-market trading.

Keefe, Bruyette & Woods (KBW) increased its 12-month price target on Webster Financial (NYSE: WBS) to $77.00 from $75.00 and kept its Outperform rating on the stock, citing the bank's solid end-of-year performance.

KBW attributed the price target bump to what it described as "strong Q4 results," noting that trends observed in the period point to strengthening loan growth momentum and improving credit quality through 2025. The research firm also highlighted Webster's most active share repurchase quarter of 2025, saying the buyback activity positions the company for continued solid results into 2026 and beyond.

In its outlook, KBW projected that Webster Financial will post double-digit growth in both EPS and tangible book value (TBV) for 2026 and 2027, and that the bank could achieve a 17% ROTCE - return on tangible common equity. To reflect these expectations, KBW raised its earnings estimates for Webster by 2% for 2026 and by 4% for 2027, while reiterating its Outperform rating.

Separately, Webster Financial Corporation released its fourth-quarter 2025 results, reporting an earnings per share of $1.59 versus analyst expectations of $1.53. Quarterly revenue was $746.2 million, above forecasts of $731.51 million. These figures constituted an earnings and revenue beat for the quarter.

Despite the favorable top- and bottom-line surprises, Webster's stock registered a slight pre-market decline following the release. The report notes that analyst firms did not announce any upgrades or downgrades in response to the earnings publication.

Taken together, KBW's revised target and the company-reported quarterly results underline a narrative of improving operating trends and shareholder-friendly capital deployment in late 2025. KBW's modest increase in estimates for 2026 and 2027 aligns with its expectation of continued earnings and TBV expansion as well as a specified ROTCE outcome.

Investors and market participants will be watching whether the strengthening loan growth momentum and the indicated credit-quality improvements persist into 2026, and whether continued buyback activity supports shareholder returns. For now, KBW maintains an Outperform stance and has adjusted near-term earnings assumptions upward in light of Webster's recent performance.

Risks

  • Market reaction to quarterly results was muted - the stock experienced a slight pre-market dip despite earnings and revenue beats, indicating potential sensitivity in the markets.
  • No analyst upgrades or downgrades were reported after the earnings release, reflecting limited immediate consensus shifts among sell-side firms.
  • KBWexpectations for continued loan growth momentum and improving credit quality through 2025 are key assumptions underlying the revised target and estimates; if these trends do not persist, projected EPS and TBV growth could be at risk.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026